{
    "id": 11341,
    "fullName": "TPM4 - ALK",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "TPM4-ALK results from the fusion of TPM4 and ALK, and leads to constitutive Alk kinase activity (PMID: 10934142). TPM4-ALK fusions have been identified in inflammatory myofibroblastic tumors and anaplastic large cell lymphoma (PMID: 10934142, PMID: 15080301).",
            "references": [
                {
                    "id": 11164,
                    "pubMedId": 15080301,
                    "title": "Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15080301"
                },
                {
                    "id": 3597,
                    "pubMedId": 10934142,
                    "title": "TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10934142"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7171,
        "geneSymbol": "TPM4",
        "terms": [
            "TPM4",
            "HEL-S-108"
        ]
    },
    "variant": "TPM4 - ALK",
    "createDate": "09/03/2015",
    "updateDate": "04/09/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 12934,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "TPM4-ALK fusions aid the diagnosis of inflammatory myofibroblastic tumor (NCCN.org).",
            "molecularProfile": {
                "id": 11390,
                "profileName": "TPM4 - ALK"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50905,
                "name": "inflammatory myofibroblastic tumor",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11390,
            "profileName": "TPM4 - ALK",
            "profileTreatmentApproaches": [
                {
                    "id": 17576,
                    "name": "ALK Inhibitor",
                    "profileName": "TPM4 - ALK"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}